Sector revisions Daiichi Sankyo Company, Limited

Equities

Market Closed - Japan Exchange Other stock markets 12:00:00 06/03/2026 pm IST			5-day change	1st Jan Change
2,867.00 ^JPY	+0.81%		-6.43%	-14.37%

26/02	Daiichi Sankyo Company, Limited Announces Board Retirements, Effective March 31, 2026	CI
26/02	Daiichi Sankyo Company, Limited Announces Retirement of Sunao Manabe as Representative Director Executive Chairperson, Effective February 26, 2026	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DAIICHI SANKYO COMPANY, LIMITED							16
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	MERCK & CO., INC.							27
	AMGEN INC.							28
	GILEAD SCIENCES, INC.							27
	NOVO NORDISK A/S							21
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							27
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	HALEON PLC							16
	Average							22
	Weighted average by Cap.							25